• +353-1-416-8900(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011 Product Image

Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011

  • Published: April 2011
  • 37 pages
  • Global Markets Direct

Sucampo Pharmaceuticals, Inc. – Product Pipeline Review – Q1 2011

Summary

Global Market Direct’s pharmaceuticals report, “Sucampo Pharmaceuticals, Inc. - Product Pipeline Review - Q1 2011” provides data on the company’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, Company’s corporate website, SEC filings, investor presentations and featured press releases, both from company and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- Sucampo Pharmaceuticals, Inc. - Brief company overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of Sucampo Pharmaceuticals, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipeline molecules in various stages of drug development, READ MORE >



List of Tables
List of Figures
Sucampo Pharmaceuticals, Inc. Snapshot
Sucampo Pharmaceuticals, Inc. Overview
Key Information
Key Facts
Sucampo Pharmaceuticals, Inc. – Research and Development Overview
Key Therapeutic Areas
Sucampo Pharmaceuticals, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
Sucampo Pharmaceuticals, Inc. – Pipeline Products Glance
Sucampo Pharmaceuticals, Inc. – Late Stage Pipeline
Phase III Products/Combination Treatment Modalities
Sucampo Pharmaceuticals, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Sucampo Pharmaceuticals, Inc.–Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
Sucampo Pharmaceuticals, Inc. – Drug Profiles
Amitiza
Product Description
Mechanism of Action
R&D Progress
Cobiprostone
Product Description
Mechanism of Action
R&D Progress
SPI-017
Product Description
Mechanism of Action
R&D Progress
Cobiprostone
Product Description
Mechanism of Action
R&D Progress
Rescula
Product Description
Mechanism of Action
R&D Progress
SPI-017
Product Description
Mechanism of Action
R&D Progress
SPI-3608
Product Description
Mechanism of Action
R&D Progress
Sucampo Pharmaceuticals, Inc. – Pipeline Analysis
Sucampo Pharmaceuticals, Inc. – Pipeline Products by Therapeutic Class
Sucampo Pharmaceuticals, Inc. - Pipeline Products By Target
Sucampo Pharmaceuticals, Inc. – Pipeline Products by Route of Administration
Sucampo Pharmaceuticals, Inc. – Pipeline Products by Molecule Type
Sucampo Pharmaceuticals, Inc. – Recent Pipeline Updates
Sucampo Pharmaceuticals, Inc. – Locations And Subsidiaries
Head Office
Financial Deals Landscape
Sucampo Pharmaceuticals, Inc., Deals Summary, 2004 to 2011
Sucampo Pharmaceuticals, Inc. Detailed Deal Summary
Licensing Agreements
Takeda Enters Into Licensing Agreement With Sucampo Pharmaceuticals
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

List of Tables
Sucampo Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
Sucampo Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
Sucampo Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
Sucampo Pharmaceuticals, Inc. – Phase III, 2011
Sucampo Pharmaceuticals, Inc. - Phase II, 2011
Sucampo Pharmaceuticals, Inc. - Phase I, 2011
Sucampo Pharmaceuticals, Inc. - Pipeline By Therapeutic Class, 2011
Sucampo Pharmaceuticals, Inc. - Pipeline By Target, 2011
Sucampo Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011
Sucampo Pharmaceuticals, Inc. – Pipeline By Molecule Type, 2011
Sucampo Pharmaceuticals, Inc. – Recent Pipeline Updates, 2011
Sucampo Pharmaceuticals, Inc., Deals Summary, 2004 to 2011

List of Figures
Sucampo Pharmaceuticals, Inc. – Pipeline by Therapy Area and Indication, 2011
Sucampo Pharmaceuticals, Inc. – Pipeline by Stage of Development, 2011
Sucampo Pharmaceuticals, Inc. – Monotherapy Products in Pipeline, 2011
Sucampo Pharmaceuticals, Inc. – Pipeline By Therapeutic Class, 2011
Sucampo Pharmaceuticals, Inc. - Pipeline By Target, 2011
Sucampo Pharmaceuticals, Inc. – Pipeline By Route of Administration, 2011

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos